iRhythm Technologies, Inc. (IRTC)
NASDAQ: IRTC · Real-Time Price · USD
185.00
-2.30 (-1.23%)
At close: Nov 3, 2025, 4:00 PM EST
185.00
0.00 (0.00%)
After-hours: Nov 3, 2025, 4:10 PM EST
iRhythm Technologies Revenue
iRhythm Technologies had revenue of $192.88M in the quarter ending September 30, 2025, with 30.74% growth. This brings the company's revenue in the last twelve months to $702.57M, up 25.45% year-over-year. In the year 2024, iRhythm Technologies had annual revenue of $591.84M with 20.13% growth.
Revenue (ttm)
$702.57M
Revenue Growth
+25.45%
P/S Ratio
8.47
Revenue / Employee
$351,287
Employees
2,000
Market Cap
5.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 591.84M | 99.16M | 20.13% |
| Dec 31, 2023 | 492.68M | 81.76M | 19.90% |
| Dec 31, 2022 | 410.92M | 88.10M | 27.29% |
| Dec 31, 2021 | 322.83M | 57.66M | 21.74% |
| Dec 31, 2020 | 265.17M | 50.61M | 23.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
IRTC News
- 3 days ago - iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook - Benzinga
- 3 days ago - iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - iRhythm Technologies Announces Third Quarter 2025 Financial Results - GlobeNewsWire
- 11 days ago - Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 18 days ago - iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025 - GlobeNewsWire
- 6 weeks ago - IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC - GlobeNewsWire
- 7 weeks ago - IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service - GlobeNewsWire